IRadimed
IRadimed (NASDAQ: IRMD) designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pumps, portable patient vital signs monitors, and ferrous metal detection systems for hospitals, ICUs, anesthesiology departments, and veterinary clinics across 60+ countries.
- Company typePublic
- Founded2004
- HeadquartersWinter Park, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What IRadimed does
IRadimed Corporation (NASDAQ: IRMD) is a US-based medical device company that designs, manufactures, and sells MRI-compatible patient care equipment, including non-magnetic intravenous (IV) infusion pump systems and portable patient vital signs monitors. Founded in 2004 by Roger Susi and headquartered in Winter Springs, Florida, the company serves hospitals, imaging centers, intensive care units, and anesthesiology departments with products specifically engineered to operate safely within MRI magnetic fields up to 30,000 Gauss at the MRI bore. Distribution spans more than 60 countries through direct enterprise field sales in the United States and a network of regional international distributors, including veterinary-focused partners Medequal and Hsien Tai.
The company's core technology centers on proprietary non-magnetic ultrasonic motors and non-ferrous components that enable safe operation in MRI Zone IV environments where conventional electromagnetic devices would pose projectile and image-interference hazards. The product portfolio includes the next-generation MRidium 3870 and legacy 3860+ IV infusion pump systems, the 3880 MRI Patient Monitor (described as the world's first portable MRI-compatible patient monitor), the FMD with TruSense ferrous metal detection system, and proprietary MRI-compatible disposables including IV infusion sets. The 3880 patient monitor integrates wireless ECG, SpO2 via Masimo SET algorithms, non-magnetic respiratory CO2, blood pressure, and temperature monitoring in a portable form factor under 10 lbs. The company maintains a portfolio of granted US, European, and Japanese patents covering MRI-compatible infusion and monitoring technology, plus the MRidium and TruSense trademarks.
IRadimed generates revenue primarily through capital equipment sales of pumps, monitors, and FMD systems, supplemented by recurring revenue from proprietary MRI-compatible disposables (IV infusion sets 1056, 1057, 1058) and subscription services such as the Dose Error Reduction System (DERS) Annual Service License for drug library management and extended warranty contracts. Go-to-market combines direct enterprise sales targeting hospital radiology, ICU, and anesthesiology departments domestically with authorized regional distributors internationally. The company uplisted to NASDAQ in June 2024 from OTC Markets, reported $83.8 million in full-year 2025 revenue (14% YoY growth) with 18 consecutive quarters of record revenue, ended Q3 2025 with $56.5 million in cash and no debt, and is guiding to $91-96 million for full-year 2026.
IRadimed firmographics
Firmographics- Name
- IRadimed
- Legal name
- IRADIMED CORPORATION
- Website
- https://iradimed.com
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IRadimed (NASDAQ: IRMD) designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pumps, portable patient vital signs monitors, and ferrous metal detection systems for hospitals, ICUs, anesthesiology departments, and veterinary clinics across 60+ countries.
- Ownership category
- akta.pro rank
IRadimed industry classification
Industry- Product category
- MRI-Compatible Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)
- akta.pro secondary industry
- IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets) (HLAMAFAG)
Keywords
Where IRadimed is headquartered
LocationHeadquarters
- HQ city
- Winter Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
IRadimed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- MRI-Compatible Medical Devices: Sale of MRI-compatible IV infusion pumps (MRidium 3870, 3860+) and patient vital signs monitoring systems (3880) as capital equipment to hospitals and imaging centers. Revenue recognized upon delivery.
- Accessories and Disposables: Sale of MRI-compatible IV infusion sets (1056, 1057, 1058) and clinical accessories designed exclusively for use with MRidium MRI Infusion systems. Recurring revenue from consumables used in procedures.
- Extended Warranty and Service Contracts: Extended warranty services and DERS Annual Service License for drug library management, with automatic renewal terms for ongoing support and updates.
- Training Services: Purchased in-service training services that must be completed within 90 days of product delivery, included in product terms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | MRI Medical Devices - Capital Equipment |
| Subscription | Annual | DERS Annual Service License |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
IRadimed product offering
Product offeringCore offering
IRadimed designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pump systems (MRidium 3870 and 3860+), the 3880 MRI patient monitor, and the FMD with TruSense ferrous metal detector, along with proprietary MRI IV infusion sets and accessories. These devices use patented non-ferrous ultrasonic motors and proprietary algorithms to safely operate within MRI magnetic fields up to 30,000 Gauss for hospitals, imaging centers, ICUs, anesthesiology departments, and veterinary clinics.
Differentiator
Problem solved
Functional benefit
Products and services
- MRidium 3870 MRI IV Infusion Pump System Next-generation MRI-compatible syringe infusion pump with non-magnetic ultrasonic motor designed for safe operation within MRI Zone IV; serves hospital radiology, ICU, and anesthesiology teams delivering IV medications at the MRI bore.
- 3880 MRI Patient Monitor Portable, non-magnetic MRI patient monitor with wireless ECG, SpO2 using Masimo algorithms, non-magnetic CO2, blood pressure, and temperature monitoring for ICU and anesthesia patients during MRI procedures.
- MRidium 3860+ MRI IV Infusion Pump System MRI-compatible non-magnetic infusion pump system allowing continuous delivery of medications within the MRI suite for sedated and critical-care patients.
- FMD Smart MRI Ferrous Metal Detection System with TruSense
Quantifiable outcome
- Enables MRI diagnosis changes in therapy and management for up to 70% of critically ill patients
- +2 more outcomes
Companies that use IRadimed
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
IRadimed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
IRadimed partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered strategic, regional and core.
- MasimostrategicMasimo founder Joe Kiani appointed to IRadimed Board of Directors in September 2025. Masimo is renowned for medical technology innovation including SET pulse oximetry algorithms used in IRadimed's 3880 MRI patient monitor.
- MedequalregionalAuthorized distributor for IRadimed non-magnetic MRI solutions in the Philippines, participating in the 78th Annual Philippine College of Radiology Conference.
- Hsien TairegionalAuthorized distributor for IRadimed non-magnetic patient monitors and IV infusion pumps in Taiwan, participating in the 59th Annual Meeting of TWSRT and International Conference of Medical Imaging.
- Global Distribution NetworkcoreRegional distributors covering 60+ countries across Americas, Europe, Middle East, Africa, Asia, and Oceania markets.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
IRadimed competitors and assessment
Company assessmentDirect peers
- ICU Medical: ICU Medical is a leading manufacturer of IV infusion pumps, including the Plum 360 and LifeShield systems, and acquired Smiths Medical in 2022. It is the most direct publicly traded peer to IRadimed in the infusion pump space, though ICU Medical's portfolio is broader and not MRI-specific.
- B. Braun Medical: B. Braun manufactures the Infusomat Space and Perfusor Space infusion pump systems used in hospitals globally. It is a direct competitor in standard infusion and has the engineering depth to enter the MRI-compatible segment.
- Philips Healthcare: Philips sells the MR400 MRI patient monitor, which IRadimed explicitly benchmarks against with its 3880 monitor. Philips is the closest direct competitor in MRI patient monitoring and also manufactures MRI scanners and broader patient monitoring portfolios.
Broad incumbents
- Becton Dickinson (BD): BD produces the Alaris, BD Pyxis, and other infusion pump platforms sold to hospitals worldwide. As a diversified medical device incumbent with deep hospital relationships, BD represents both a peer and a potential competitor if it elects to develop an MRI-compatible infusion platform.
- Baxter International: Baxter's Sigma Spectrum and Novum infusion pumps are widely deployed in U.S. hospitals. While not MRI-specific, Baxter competes for the same hospital infusion budgets and could pursue MRI-compatible variants using its R&D scale.
- GE Healthcare: GE Healthcare manufactures MRI scanners, anesthesia machines, and patient monitors used in MRI environments. As the dominant MRI system vendor, it has unique leverage to bundle its own MRI-compatible accessories against IRadimed's standalone offerings.
Emerging players
- Masimo: Masimo's SET pulse oximetry algorithms are integrated into IRadimed's 3880 monitor, and Masimo founder Joe Kiani joined IRadimed's board in September 2025. Masimo is a leader in non-invasive patient monitoring and is a natural adjacent/partner in the MRI monitoring category.
- Terumo Medical: Terumo manufactures infusion systems and is expanding its hospital presence in the Americas. While not focused on MRI-compatible devices, it is a relevant peer for infusion consumables and pumps in critical care settings.
- Fresenius Kabi: Fresenius Kabi manufactures the Ivenix infusion pump platform and is a major player in clinical nutrition and IV therapy. Comparable to IRadimed in serving hospital infusion workflows, though focused on non-MRI environments.
- Mindray: Mindray produces a broad portfolio of patient monitoring and infusion pump devices sold internationally, often at lower price points than Western OEMs. It is an emerging peer with growing presence in U.S. and European hospital accounts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
IRadimed social profiles
Digital presenceIRadimed financial estimates
Financial estimateRevenue estimate
Valuation estimate
IRadimed leadership team
Management profileNumber of profiles
Profiles8 records
IRadimed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IRadimed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IRadimed
What does IRadimed do?
IRadimed designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pump systems (MRidium 3870 and 3860+), the 3880 MRI patient monitor, and the FMD with TruSense ferrous metal detector, along with proprietary MRI IV infusion sets and accessories. These devices use patented non-ferrous ultrasonic motors and proprietary algorithms to safely operate within MRI magnetic fields up to 30,000 Gauss for hospitals, imaging centers, ICUs, anesthesiology departments, and veterinary clinics.
Is IRadimed a public or private company?
IRadimed is a public company. It is classified as public and is currently operating.
When was IRadimed founded?
IRadimed was founded in 2004. It employs 101 to 250 people.
Where is IRadimed based?
IRadimed is headquartered in Winter Park, United States, in the North America region.
How does IRadimed make money?
Four revenue lines are on record. MRI-Compatible Medical Devices are the primary driver. The others are accessories and Disposables, extended Warranty and Service Contracts and training Services.
Who are IRadimed's main competitors?
Direct peers on record are ICU Medical, B. Braun Medical and Philips Healthcare. Broad incumbents are Becton Dickinson (BD), Baxter International and GE Healthcare. Emerging players are Masimo, Terumo Medical, Fresenius Kabi and Mindray.
Does IRadimed have an API?
No public API is recorded for IRadimed.
What industry is IRadimed in?
IRadimed's product category is MRI-Compatible Medical Devices. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLAMAFAG, IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets). Its NAICS code is 334510 and its SIC code is 3845.